# Ted Feldman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ted-feldman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,187 |
| Field | Cardiac Valve Diseases and Treatments |
| h-index | 94 |
| i10-index | 253 |
| Last Known Institution | Edwards Lifesciences (United States) |
| OpenAlex ID | https://openalex.org/A5002451590 |
| ORCID iD | https://orcid.org/0000-0003-1066-4962 |
| Works | 549 |

## Researcher papers

- [ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article](https://scholariq.org/papers/acc-aha-scai-2005-guideline-update-for-percutaneous-coronary-intervention/)
- [2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention](https://scholariq.org/papers/2007-focused-update-of-the-acc-aha-scai-2005-guideline-update-for-percutaneous/)
- [Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II](https://scholariq.org/papers/anatomical-and-clinical-characteristics-to-guide-decision-making-between/)
- [Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial](https://scholariq.org/papers/percutaneous-coronary-intervention-versus-coronary-artery-bypass-grafting-in/)
- [Assessment of the SYNTAX score in the Syntax study](https://scholariq.org/papers/assessment-of-the-syntax-score-in-the-syntax-study/)
- [1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification](https://scholariq.org/papers/1-year-outcomes-of-transcatheter-mitral-valve-replacement-in-patients-with/)
- [Transcatheter Mitral Valve Replacement in Native Mitral Valve Disease With Severe Mitral Annular Calcification](https://scholariq.org/papers/transcatheter-mitral-valve-replacement-in-native-mitral-valve-disease-with/)
- [Thirty-Day Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Valve-in-Valve), Failed Surgical Rings (Valve-in-Ring), and Native Valve With Severe Mitral Annular Calcification (Valve-in-Mitral Annular Calcification) in the United States](https://scholariq.org/papers/thirty-day-outcomes-of-transcatheter-mitral-valve-replacement-for-degenerated/)

## Researcher topics

- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)
- [Infective Endocarditis Diagnosis and Management](https://scholariq.org/topics/infective-endocarditis-diagnosis-and-management/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac Structural Anomalies and Repair](https://scholariq.org/topics/cardiac-structural-anomalies-and-repair/)

## Researcher university

- [Edwards Lifesciences (United States)](https://scholariq.org/institutions/edwards-lifesciences-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.